全文获取类型
收费全文 | 3178篇 |
免费 | 140篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 62篇 |
妇产科学 | 25篇 |
基础医学 | 290篇 |
口腔科学 | 78篇 |
临床医学 | 316篇 |
内科学 | 409篇 |
皮肤病学 | 16篇 |
神经病学 | 167篇 |
特种医学 | 140篇 |
外科学 | 760篇 |
综合类 | 441篇 |
预防医学 | 170篇 |
眼科学 | 33篇 |
药学 | 273篇 |
3篇 | |
中国医学 | 60篇 |
肿瘤学 | 100篇 |
出版年
2024年 | 15篇 |
2023年 | 60篇 |
2022年 | 90篇 |
2021年 | 130篇 |
2020年 | 87篇 |
2019年 | 87篇 |
2018年 | 84篇 |
2017年 | 94篇 |
2016年 | 83篇 |
2015年 | 107篇 |
2014年 | 230篇 |
2013年 | 197篇 |
2012年 | 168篇 |
2011年 | 191篇 |
2010年 | 150篇 |
2009年 | 164篇 |
2008年 | 157篇 |
2007年 | 175篇 |
2006年 | 133篇 |
2005年 | 120篇 |
2004年 | 84篇 |
2003年 | 89篇 |
2002年 | 69篇 |
2001年 | 66篇 |
2000年 | 58篇 |
1999年 | 55篇 |
1998年 | 58篇 |
1997年 | 37篇 |
1996年 | 31篇 |
1995年 | 35篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 25篇 |
1991年 | 26篇 |
1990年 | 17篇 |
1989年 | 15篇 |
1988年 | 17篇 |
1987年 | 21篇 |
1986年 | 20篇 |
1985年 | 15篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1974年 | 2篇 |
排序方式: 共有3369条查询结果,搜索用时 3 毫秒
91.
目的:比较单侧开颅大脑镰切开术与双侧骨窗幵颜术治疗双额叶脑挫裂伤的临床疗效。方法回顾性分析我院神经外科2015年1~12月收治的72例双额叶脑挫裂伤患者的治疗情况,其中32例采用单侧开颅大脑镰切开术(单侧开颅组),40例采用常规双侧骨窗开颅术(双侧开颅组),比较两组患者的手术时间、住院时间及术中输血量,所有患者术后3个月按GOS分级评价预后,术后6个月检查语言和精神障碍发生情况。结果单侧开颅组平均手术时间、平均住院时间和术中平均输血量分别为(109.3±22.8) min、(19.4±2.8) d和(342.6±22.8) mL,均明显少于双侧开颅组的(203.5±37.4) min、(25.7±4.2) d和(605.4±69.7) mL,差异均有统计学意义(P<0.05);术后3个月,单侧开颅组恢复良好率为53.13%(17/32),明显高于双侧开颅组的35.00%(14/40),差异有显著统计学意义(P<0.01)。术后6个月,单侧开颅组语言和精神障碍发生率分别为21.88%(7/32)、12.50%(4/32),明显低于双侧开颅组的45.00%(18/40)、32.50%(13/40),差异均有统计学意义(P<0.05)。结论单侧开颅大脑镰切开术治疗双额叶脑挫裂伤减少手术的二次损伤,缩短手术时间,对提高患者的预后具有积极的作用。 相似文献
92.
目的 分析不同心肌保护方法 在双瓣膜置换术中对心肌的保护效果评价. 方法 整群选取90例行双瓣膜置换术的患者随机分为顺行灌注组、逆行灌注组、顺行+逆行灌注组,各30例,比较3组相关观察指标. 结果 顺行灌注、逆行灌注及联合灌注组乳酸浓度分别为(14.8±1.2)、(17.5±1.2)、(14.6±1.2);血清CK-MB 分别为(63.2±25.5)、(78.3± 21.3)、(66.7±19.1)U/L;血清cTnl分别为(1.4±0.3)、(1.8±0.5)、(1.4±0.2)ng/mL;顺行及联合灌注组患者心肌乳酸浓度低于逆行灌注组(P<0.05);顺行灌注组及联合灌注组磷酸肌酸激酶同工酶及血清心肌肌钙蛋白I浓度均显著低于逆行灌注组(P<0.05). 结论 顺行灌注、逆行灌注及联合灌注保护心肌均具有一定的效果,顺行及联合灌注效果更佳,顺行灌注操作更加简单. 相似文献
93.
94.
95.
Farrukh Aslam Khalid Muhammad Younas Mehrose Muhammad Saleem Muhammad Amin Yousaf Abdul Malik Mujahid Saif Ur Rehman Sania Ahmad Moazzam Nazeer Tarar 《Burns : journal of the International Society for Burn Injuries》2019,45(1):69-75
The treatment of keloid and hypertrophic scar is challenging with no universally accepted mode for permanent ablation. Conventional therapies yield unpredictable results, significant complications and require elaborate hardware.
Objective
The objective was to establish the safety and efficacy of intralesional 5-fluorouracil (5-FU) for the treatment of keloids and hypertrophic scars.Study design
Randomized controlled trial (RCT).Place and duration
It was conducted at the Jinnah Burn and Reconstructive Surgery Center/Allama Iqbal Medical College, Lahore, Pakistan from May 2012 to March 2013.Subjects and methods
We included 120 patients divided in two groups. The group A patients received intralesional triamcinolone acetonide (TAC) and the group B patients received both 5-FU and TAC. 8 injections at a week interval were given and patients were evaluated at the start of treatment and then at 4th and at 8th week during the treatment and then 4 weeks after the end of treatment. Patents were assessed for mean reduction in scar height, efficacy and complications.Results
Total of 108 patients completed the study. The mean reduction in the scar height in group B (5-FU + TAC) 1.144 + .4717 was markedly better than that of group A (TAC alone) 1.894 + 1.0751 (t = 4.781, p = .000). The efficacy (defined previously as >50% reduction in initial scar height) was superior in group B 44 (77.2%) than that of group A 25 (49.0% (X2 = 9.260, p = .002). Recurrence was seen in 39.2% (20) of patients of the group A while in only 17.5% (10) of the cases of group B (P = 0.012). Mean follow up was of 22 months.Conclusion
5-FU + TAC is safe, easy to administer and effective treatment for problematic scars and has the lower rate of recurrence on larger follow up. 相似文献96.
Saura D Campos JV Villegas M Picó F de la Morena G Valdés-Chávarri M 《International journal of cardiology》2008,129(1):e7-e9
Heart–hand syndromes show substantial clinical and genetic heterogeneity. The unusual case of a patient with a heart–hand syndrome consisting of preaxial polydactylia, postaxial syndactylia, parachute mitral valve, mild subaortic stenosis, and double outlet right ventricle is presented and discussed. The importance of distinguishing Holt–Oram syndrome from its phenocopies and other heart–hand syndromes is underlined. 相似文献
97.
Srikanth Vedachalam Gokulakrishnan Balasubramanian Garrie J Haas Somashekar G Krishna 《World journal of gastroenterology : WJG》2020,26(20):2550-2558
Left ventricular assist devices(LVAD) are increasingly become common as life prolonging therapy in patients with advanced heart failure. Current devices are now used as definitive treatment in some patients given the improved durability of continuous flow pumps. Unfortunately, continuous flow LVADs are fraught with complications such as gastrointestinal(GI) bleeding that are primarily attributed to the formation of arteriovenous malformations. With frequent GI bleeding, antiplatelet and anticoagulation therapies are usually discontinued increasing the risk of life-threatening events. Small bowel bleeds account for 15%as the source and patients often undergo multiple endoscopic procedures.Treatment strategies include resuscitative measures and endoscopic therapies.Medical treatment is with octreotide. Novel treatment options include thalidomide, angiotensin converting enzyme inhibitors/angiotensin Ⅱ receptor blockers, estrogen-based hormonal therapies, doxycycline, desmopressin and bevacizumab. Current research has explored the mechanism of frequent GI bleeds in this population, including destruction of von Willebrand factor,upregulation of tissue factor, vascular endothelial growth factor, tumor necrosis factor-α, tumor growth factor-β, and angiopoetin-2, and downregulation of angiopoetin-1. In addition, healthcare resource utilization is only increasing in this patient population with higher admissions, readmissions, blood product utilization, and endoscopy. While some of the novel endoscopic and medical therapies for LVAD bleeds are still in their development stages, these tools will yet be crucial as the number of LVAD placements will likely only increase in the coming years. 相似文献
98.
摘 要 目的: 用火焰原子吸收分光光度计和原子双道荧光光度计分别对不同产地冻干地黄中的Pb、Cd、Cu、As和Hg 5种重金属和有害元素进行检测。方法: 采用硝酸-高氯酸对样品进行消化后,采用原子吸收分光光度法测定Pb、Cd和Cu含量,采用原子荧光光度法测定As和Hg的含量。 结果: 各元素线性关系良好,相关系数均大于0.997 4,平均回收率为97.88%~100.90%,RSD为0.019%~4.20%(n=6),同时发现10批样品中的4批样品部分重金属和有害元素超过《中国药典》限量标准。 结论:该方法准确度高,操作简便,快捷,适用于冻干地黄中重金属和有害元素的测定。 相似文献
99.
Brijesh Takkar Vinod Kumar Renu Agrawal Raghav Ravani Shorya Azad 《Saudi Journal of Ophthalmology》2015,29(4):315-316
Small intraocular foreign body in the outer coats of the eye may be wrongly interpreted as optic nerve head on ultrasound imaging. Such errors can be avoided by performing multiple sonography scans in different axes. 相似文献
100.
目的研究应用头孢哌酮/舒巴坦治疗耐药菌及二重感染患者进行的临床效果。方法回顾性分析2012年9月-2013年9月应用头孢哌酮/舒巴坦进行治疗的294例耐药菌感染患者及二重感染患者临床资料,采用SPSS 19.0软件进行统计处理。结果共培养出336株病原菌,革兰阴性菌267株占79.46%,革兰阳性菌69株占20.54%;革兰阴性菌对头孢哌酮/舒巴坦敏感率达79.78%;革兰阳性菌对头孢哌酮/舒巴坦敏感率达82.61%;127例二重感染患者培养出病原菌201株,均为革兰阴性菌,其对头孢哌酮/舒巴坦敏感率达80.10%。结论应用头孢哌酮/舒巴坦对耐药菌及二重感染患者进行治疗,效果显著。 相似文献